The stock is in a powerful but volatile long-term uptrend, evidenced by a staggering 204.07% gain over the past year. As of the latest close at $33.63, the price sits approximately 66% of the way up from its 52-week low of $7.78 towards its high of $46.75, indicating it has retreated significantly from recent peaks but remains well above its lows, suggesting a cooling off from overextended momentum. Recent momentum has been exceptionally strong but is showing signs of a sharp reversal; the stock surged 35.60% over the past month and 90.75% over three months, yet the price has fallen -0.59% on the day and from a peak near $46 in late May, signaling a potential short-term trend exhaustion or profit-taking phase following the parabolic move. Key technical support is anchored at the 52-week low of $7.78, with immediate resistance at the recent high of $46.75; a sustained break above $46.75 would signal a resumption of the bull trend, while a breakdown below key moving averages could see a test of lower support levels. The stock's beta of 1.469 confirms it is approximately 47% more volatile than the broader market (SPY), which is critical for risk assessment given its recent 41.88% maximum drawdown and the high-volume swings typical of speculative growth names.

Revenue growth is highly inconsistent and currently negative; the most recent quarterly revenue was $44.8 million, representing a year-over-year decline of -18.64%, and this follows a volatile pattern from the prior quarter's $52.4 million, indicating significant lumpiness in contract timing rather than steady organic growth. The company is deeply unprofitable with a net income of -$40.0 million for the quarter and a gross margin of 30.24%, though this gross margin represents an improvement from the deeply negative -23.54% in Q2 2025, showing some operational progress amidst heavy losses. The balance sheet shows a strong current ratio of 4.96 and negative debt-to-equity of -0.50, indicating net cash position, but this is overshadowed by severe cash burn with trailing twelve-month free cash flow at -$55.95 million and an ROE of 11.13% that is likely distorted by equity issuance, highlighting a fundamental reliance on external financing to fund operations and growth.